Representative before the EPO

Company dna cabinet lecca
no operation time available
416.66
1 office
active in Legal Services

We have observed 33 EP applications Patricia S. Lecca has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11726502

A NOVEL PROCESS FOR PREPARATION OF BOSENTAN

IPC classification:
A61K 31/505, A61P 11/00, C07D 239/545
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP11837675

PROCESS FOR PREPARING BENDAMUS TINE HYDROCHLORIDE MONOHYDRATE

IPC classification:
A61K 31/4184, A61P 35/00, C07D 235/16
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP11842990

FINGOLIMOD POLYMORPHS AND THEIR PROCESSES

IPC classification:
A61K 31/137, A61P 37/02, C07C 213/00, C07C 215/28
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP11173119

Combination vaccine with whole cell pertussis

IPC classification:
A61K 39/05, A61K 39/08, A61K 39/10, A61K 39/102, A61K 39/13, A61K 39/29
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11172591

Combination vaccine with acellular pertussis

IPC classification:
A61K 39/05, A61K 39/08, A61K 39/10, A61K 39/102, A61K 39/13, A61K 39/29
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11777945

RAPID GENOTYPING ANALYSIS FOR HUMAN PAPILLOMAVIRUS AND THE DEVICE THEREOF

IPC classification:
C12Q 1/70, G01N 33/48
Agent:
Patricia S. Lecca, Cabinet Lecca
Agent:
inCompass IP Europe Ltd
Status:
EXAMINATION IN PROGRESS
EP12828954

SYSTEM AND METHOD FOR LOCATING AND IDENTIFYING FUNCTIONAL NERVES INNERVATING WALL OF ARTERIES AND CATHETERS FOR SAME

IPC classification:
A61B 5/00, A61B 18/14
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP13150187

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

IPC classification:
A61K 38/44, A61K 47/48, A61P 17/00, A61P 17/16, A61P 35/00, C12N 9/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Victor Segalen Bordeaux 2
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12834337

BEVERAGE SYSTEM WITH AERATION

IPC classification:
A47J 31/00, B67D 1/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
PATENT GRANTED
EP12833609

ENERGY MANAGEMENT SYSTEM

IPC classification:
G01R 22/00, H04W 24/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14181904

Compositions comprising calcium, magnesium, zinc, and vitamin D3 for the prevention and amelioration of osteoporosis

IPC classification:
A61K 31/593, A61K 33/06, A61K 33/30, A61P 19/10, A61P 43/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP12771074

CENTRIFUGAL FLUID RING REACTOR

IPC classification:
B01F 7/00, B01J 8/10, B01J 19/08, B01J 19/18, C10G 29/20, C10L 1/02
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP13760612

VAGINAL REMODELING DEVICE AND METHOD

IPC classification:
A61B 18/02
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP13720262

POLYPEPTIDES AS APELIN INHIBITORS AND USES THEREOF

IPC classification:
C07K 14/47
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Applicant:
Université Paris Sud (UPS) Paris XI
Agent:
Denise Marie Hirsch, Inserm Transfert
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION IN PROGRESS
EP14191824

Integrated stacking device and conveyor

IPC classification:
B65G 60/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12183621

Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof

IPC classification:
A61K 35/74, A61P 1/00, A61P 11/00, A61P 11/06, A61P 13/00, A61P 31/04, A61P 37/08, C12N 1/06, C12N 1/20, C12R 1/225, C12R 1/25
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12877327

PROCESS FOR PREPARING CRYSTALLINE SORAFENIB TOSYLATE

IPC classification:
A61K 31/44, A61P 35/00, C07D 213/81
Agent:
Ibrahim Iskender, Destek Patent Inc
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14700063

SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

IPC classification:
A61K 38/44, A61K 47/48, A61P 17/00, A61P 17/16, A61P 35/00, C12N 9/02
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14740925

DEVICE FOR RELIABLY MOVING ARTICLE FROM CONVEYOR SURFACE

IPC classification:
B65G 47/82
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP14741170

PROCESS FOR PREPARATION OF FINGOLIMOD AND ITS SALTS

IPC classification:
C07C 209/50, C07C 211/17, C07C 215/28
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP14822663

ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING IMATINIB MESYLATE

IPC classification:
A61K 9/16, A61K 9/20
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
GRANT OF PATENT INTENDED
EP15152886

New compositions and methods of treating and/or preventing chronic obstructive pulmonary disease

IPC classification:
A61K 31/198, A61K 31/395, A61K 31/4995, A61K 45/06, A61P 11/00
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université de Bordeaux
Applicant:
Centre Hospitalier Universitaire de Bordeaux
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15155202

Novel voltage dependent ion channel fusions and method of use thereof

IPC classification:
C07K 14/705, G01N 33/542
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Université de Bordeaux
Applicant:
Institut Polytechnique de Bordeaux
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP12180334

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180487

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12180375

Treatment of heart failure in non-human mammals with an aldosterone antagonist

IPC classification:
A61K 31/401, A61K 31/50, A61K 31/501, A61K 31/55, A61K 31/585, A61K 45/06, A61P 9/04
Agent:
Philippe Becker, Cabinet Becker & Associés
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14864924

PROCESS FOR CRYSTALLINE PEMETREXED DIPOTASSIUM SALT

IPC classification:
A61K 31/519
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15188615

NOVEL METHODS AND KITS FOR DETECTING OF UREA CYCLE DISORDERS USING MASS SPECTROMETRY

IPC classification:
G01N 33/58, G01N 33/68
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
Request for examination was made
EP15729243

HIGH THROUGHPUT QUANTIFICATION AND CHARACTERIZATION OF VIRUSES AND PRODUCTS THEREOF

IPC classification:
C12N 7/00, G01N 15/02, G01N 21/49, G01N 30/46
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15815760

PEMETREXED DIPOTASSIUM FORMULATIONS

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15819144

AN IMPROVED PROCESS FOR THE PREPARATION OF ENZALUTAMIDE

IPC classification:
C07D 233/86
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
EXAMINATION REQUESTED
EP15862402

SUBSTANTIALLY PURE VEMURAFENIB AND ITS SALTS

IPC classification:
A61K 31/437, C07D 471/04
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
Request for examination was made
EP16732884

NOVEL METHOD FOR EFFICIENT PURIFICATION OF HUMAN SERUM ALBUMIN

IPC classification:
C07K 1/16, C07K 1/18, C07K 1/20, C07K 14/76, C07K 19/00
Agent:
Patricia S. Lecca, Cabinet Lecca
Status:
Request for examination was made

Please Sign in to use this feature